PEG-Polyphenolic Coatings for Medical Device Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical devices struggle with achieving sustained and effective drug delivery to implant sites due to challenges in adhesion of coatings on substrates with varying surface energies, particularly metals and polyolefins, and existing coatings are complex, costly, and not suitable for a wide range of surfaces.
Innovation Solution
A blend of polyethylene glycol and polyphenolic polymers is used to create a coating that provides improved adhesion, biocompatibility, and sustained drug delivery, suitable for various substrates, including metals and polyolefins, with a simplified manufacturing process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If standard adhesive or coating formulations are used, then they wet out and bond to high surface energy surfaces such as metal or ABS plastic, but they fail to bond to low surface energy polyolefins that include polypropylene and polyethylene
Solution Approach 1:
The patent modifies the surface energy parameters of the coating formulation by incorporating specific surfactants and adhesion promoters that can adjust their chemical properties to match different substrate surface energies, enabling effective bonding across high and low surface energy materials
Solution Approach 2:
The coating is formulated as a composite material system combining multiple components including polymers, surfactants, and adhesion promoters that work synergistically to provide universal adhesion performance on diverse substrates with varying surface energy characteristics
2Reliability
If surface treatments such as UV light exposure or chromic acid treatment are used to raise substrate surface energy, then coating adhesion improves, but the process complexity and energy cost increase
Solution Approach 1:
The coating formulation itself contains pre-integrated adhesion enhancement components that perform the surface modification function during the coating application process, eliminating the need for separate preliminary surface treatment steps
Solution Approach 2:
The coating system is self-sufficient in providing adhesion enhancement through its own chemical composition, requiring no external surface treatment equipment or additional processing steps to modify the substrate before coating
3Duration of action of moving object
If multiple coating layers are used to achieve sustained drug delivery, then drug delivery efficacy improves, but the manufacturing complexity and cost increase
Solution Approach 1:
The patent combines multiple functional components including drug reservoir, release control mechanism, and adhesion layer into a single integrated coating formulation, achieving sustained drug delivery without requiring multiple separate coating layers
Solution Approach 2:
The coating formulation is designed as a multi-functional system that simultaneously provides adhesion, drug loading, controlled release, and biocompatibility in a single layer, eliminating the need for specialized multi-layer structures
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coating ensures effective and sustained release of antimicrobial agents like rifampin and minocycline, reducing bacterial infections and biofilm formation on implants, while being biodegradable and easy to apply, thus addressing the challenges of substrate compatibility and drug delivery efficacy.
Implementation Method 1
In order for a liquid (such as a coating solution) to optimally adhere to a surface, it must thoroughly 'wet out' the surface to which it is to be bonded. 'Wetting out' means that the liquid flows and covers a surface to maximize the contact area and the attractive forces between the liquid and solid surface.
Implementation Method 2
In order to achieve local, continuous delivery of a drug, medical devices can be coated with a drug in a manner that would allow the sustained and localized release of the drug.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to coatings comprising polyethylene glycol and at least one polyphenolic polymer. In particular, the polyphenolic polymer could be selected from the group consisting of tyrosine-derived polyarylates, linear polyesteramides, dihydroxybenzoate polymers, and resorcinol-derived polymers. The coating of the present invention may also include a drug, such as an antibiotic. The coatings of the present invention are suitable for use as coatings for medical devices, such as orthopedic pins or stents.